Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Receipt of Weight Management Services Among Patients With OSA and Obesity.

CHEST pulmonary·2026
Same author

Receipt of glucagon-like peptide-1 receptor agonists among rural patients with obstructive sleep apnea and excess weight.

Annals of the American Thoracic Society·2026
Same author

Improving community care lung cancer screening by implementation of centralized support: a quality improvement initiative.

Annals of the American Thoracic Society·2026
Same author

When to assess responses to treatments in adaptive interventions? An experimental analysis of assessment timing in a smoking cessation treatment in the context of lung cancer screening.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Sunshine Act expansion and the prescription of generic medications by advanced practice providers.

Health affairs scholar·2026
Same author

Proactive Text Messaging Outreach for Tobacco Cessation Among Patients With COPD Who Smoke: A Randomized Pilot.

Tobacco use insights·2025
Same journal

Impact of Health Insurance Coverage on Diabetes Care Quality: A Systematic Review and Meta-analysis of Racial, Ethnic, and Gender Disparities in U.S. Adults with Type 2 Diabetes.

Journal of general internal medicine·2026
Same journal

Assessment of Physician Advocacy Engagement: A Scoping Review and Proposal of an Assessment Tool.

Journal of general internal medicine·2026
Same journal

Relative Burden of Social Determinants of Health on Diverse Populations of Health Resources and Services Administration Health Centers.

Journal of general internal medicine·2026
Same journal

Addressing Moral Distress Among Gender-Affirming Healthcare Professionals.

Journal of general internal medicine·2026
Same journal

Trainee-Led Patient Education to Increase Advance Care Planning in a Geriatric Primary Care Clinic.

Journal of general internal medicine·2026
Same journal

Scholarly Outcomes of a Small Projects Grant Program.

Journal of general internal medicine·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Missing potential opportunities to reduce repeat COPD exacerbations.

Anne C Melzer1, Laura M Feemster, Jane E Uman

  • 1Department of Pulmonary and Critical Care Medicine, University of Washington, 1959 N.E. Pacific, Campus Box 356522, Seattle, WA 98195-6522, USA. acmelzer@u.washington.edu

Journal of General Internal Medicine
|December 11, 2012
PubMed
Summary
This summary is machine-generated.

Few patients with COPD exacerbations received inhaled therapies like long-acting beta-agonists (LABA) or inhaled corticosteroids (ICS) that can reduce future events. This study examined medication initiation after COPD exacerbations.

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Related Experiment Videos

Last Updated: May 16, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Area of Science:

  • Pulmonary Medicine
  • Pharmacotherapy
  • Health Services Research

Background:

  • Long-acting beta-agonists (LABA) and inhaled corticosteroids (ICS) are proven to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD) exacerbations.
  • However, their initiation patterns after a COPD exacerbation event are not well-documented.

Purpose of the Study:

  • To investigate the rate of initiation of LABA and/or ICS in patients following a COPD exacerbation.
  • To identify factors associated with the prescription of these inhaled therapies after an exacerbation.

Main Methods:

  • Retrospective analysis of patients with COPD experiencing an exacerbation within the Veterans Affairs Integrated Service Network (VISN)-20.
  • Assessment of new ICS or LABA prescription within 180 days post-exacerbation.
  • Logistic regression used to determine predictors of new inhaled therapy initiation.

Main Results:

  • Out of 2,760 patients with COPD exacerbations, only 34.1% received new LABA or ICS therapy within 180 days.
  • The majority (93.1%) were on minimal long-acting medication prior to the exacerbation.
  • Factors associated with lower odds of receiving additional therapy included older age, current tobacco use, ipratropium bromide use, prior exacerbations, depression, CHF, and diabetes.

Conclusions:

  • A significant proportion of COPD patients are not prescribed guideline-recommended inhaled therapies after an exacerbation.
  • This suggests a potential gap in care for managing COPD exacerbations and preventing future events.